SNSE•benzinga•
Sensei Biotherapeutics Reports FY24 Net Loss Per Share Of $(1.20) Compared With $(1.22) YoY; Says Company Has Cash Runway Into Q2 Of 2026
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 28, 2025 by benzinga